Xin Pang - Search Results

Year	Number of Results
2002	1
2004	9
2005	6
2008	1
2009	2
2010	2
2011	3
2012	7
2013	9
2014	5
2015	6
2016	7
2017	12
2018	25
2019	24
2020	24
2021	9
2022	14
2023	23
2024	3

1

A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy.

Liu C, Liu X, Xiang X, Pang X, Chen S, Zhang Y, Ren E, Zhang L, Liu X, Lv P, Wang X, Luo W, Xia N, Chen X, Liu G. Liu C, et al. Among authors: pang x. Nat Nanotechnol. 2022 May;17(5):531-540. doi: 10.1038/s41565-022-01098-0. Epub 2022 Apr 11. Nat Nanotechnol. 2022. PMID: 35410368

2

Gender-specific effects of oxidative balance score on the prevalence of diabetes in the US population from NHANES.

Wu C, Ren C, Song Y, Gao H, Pang X, Zhang L. Wu C, et al. Among authors: pang x. Front Endocrinol (Lausanne). 2023 May 4;14:1148417. doi: 10.3389/fendo.2023.1148417. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37214249 Free PMC article.

3

The maintenance of an oral epithelial barrier.

Wang SS, Tang YL, Pang X, Zheng M, Tang YJ, Liang XH. Wang SS, et al. Among authors: pang x. Life Sci. 2019 Jun 15;227:129-136. doi: 10.1016/j.lfs.2019.04.029. Epub 2019 Apr 16. Life Sci. 2019. PMID: 31002922 Review.

4

Peptide-drug co-assembling: A potent armament against cancer.

Wu C, Wang M, Sun J, Jia Y, Zhu X, Liu G, Zhu Y, Guan Y, Zhang Z, Pang X. Wu C, et al. Among authors: pang x. Theranostics. 2023 Sep 25;13(15):5322-5347. doi: 10.7150/thno.87356. eCollection 2023. Theranostics. 2023. PMID: 37908727 Free PMC article. Review.

5

Beyond Antibiotics: Photo/Sonodynamic Approaches for Bacterial Theranostics.

Pang X, Li D, Zhu J, Cheng J, Liu G. Pang X, et al. Nanomicro Lett. 2020 Jul 10;12(1):144. doi: 10.1007/s40820-020-00485-3. Nanomicro Lett. 2020. PMID: 34138184 Free PMC article. Review.

6

Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis.

Wang X, Xia Z, Wang H, Wang D, Sun T, Hossain E, Pang X, Liu Y. Wang X, et al. Among authors: pang x. Theranostics. 2023 May 21;13(10):3224-3244. doi: 10.7150/thno.81520. eCollection 2023. Theranostics. 2023. PMID: 37351162 Free PMC article. Review.

7

Advances in Hyaluronic Acid-Based Drug Delivery Systems.

Jiao Y, Pang X, Zhai G. Jiao Y, et al. Among authors: pang x. Curr Drug Targets. 2016;17(6):720-30. doi: 10.2174/1389450116666150531155200. Curr Drug Targets. 2016. PMID: 26028046 Review.

8

LncRNA SELL/L-selectin promotes HPV-positive HNSCC progression and drives fucoidan-mediated therapeutic strategies.

Wang S, Pang X, Tong L, Fan H, Jiang J, Zhao M, Yu X, Li M, Liang J, Fan Y, Zhang X, Tang Y, Sun Y, Liang X. Wang S, et al. Among authors: pang x. Acta Biomater. 2023 Sep 1;167:436-448. doi: 10.1016/j.actbio.2023.06.011. Epub 2023 Jun 15. Acta Biomater. 2023. PMID: 37330030

9

NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and Therapy.

Shi Y, Pang X, Wang J, Liu G. Shi Y, et al. Among authors: pang x. Adv Healthc Mater. 2018 Jun;7(11):e1800053. doi: 10.1002/adhm.201800053. Epub 2018 Mar 12. Adv Healthc Mater. 2018. PMID: 29527836 Review.

10

Sulfur Oxidation in the Acidophilic Autotrophic Acidithiobacillus spp.

Wang R, Lin JQ, Liu XM, Pang X, Zhang CJ, Yang CL, Gao XY, Lin CM, Li YQ, Li Y, Lin JQ, Chen LX. Wang R, et al. Among authors: pang x. Front Microbiol. 2019 Jan 10;9:3290. doi: 10.3389/fmicb.2018.03290. eCollection 2018. Front Microbiol. 2019. PMID: 30687275 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

164 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year